Mark S. La Shell, MD, Christopher W. Calabria, MD, James M. Quinn, MD 

Slides:



Advertisements
Similar presentations
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Advertisements

Characteristics of childhood peanut allergy in the Australian Capital Territory, 1995 to 2007 Raymond James Mullins, MBBS, PhD, FRACP, FRCPA, Keith B.G.
D-dimer: A biomarker for antihistamine-resistant chronic urticaria
Mark S. La Shell, MD, Christopher W. Calabria, MD, James M. Quinn, MD 
Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 
What drives prescription patterns in pediatric asthma management?
Evaluation of National Institute of Allergy and Infectious Diseases/Food Allergy and Anaphylaxis Network criteria for the diagnosis of anaphylaxis in.
Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischemic heart disease, and mortality  Allan Linneberg,
Allergen immunotherapy: A practice parameter third update
Risk of an asthma exacerbation after bariatric surgery in adults
Fatty acids, inflammation, and asthma
Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischemic heart disease, and mortality  Allan Linneberg,
Advances in food allergy in 2015
Cow's milk epicutaneous immunotherapy in children: A pilot trial of safety, acceptability, and impact on allergic reactivity  Christophe Dupont, MD, PhD,
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
David A. Khan, MD  Journal of Allergy and Clinical Immunology 
Is 9 more than 2 also in allergic airway inflammation?
Desensitization to Chemotherapeutic Agents
Fatty acids, inflammation, and asthma
Safety of allergen immunotherapy: A 10-year prospective study
An Infant with Atopic Dermatitis and Itching After Ingestion of Milk
Hospitalization rates and prognosis of patients with anaphylactic shock in Denmark from 1995 through 2012  Anni Nørgaard Jeppesen, MD, Christian Fynbo.
NAEPP Expert Panel Report
Rising prevalence of asthma is sex-specific in a US farming population
Advancing asthma care: The glass is only half full!
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Physician needs in health informatics: Just ask the docs
Peter M. Wolfgram, MD, David B. Allen, MD 
Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA 
Phillip Lieberman, MD, Michael Tankersley, MD 
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
News & Notes Journal of Allergy and Clinical Immunology
Phillip Lieberman, MD, David Golden, MD 
Ovalbumin content of influenza vaccines
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Biosimilars and drug development in allergic and immunologic diseases
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 
Sharon Seth, MD, David A. Khan, MD 
Children's compliance with allergen immunotherapy according to administration routes  Giovanni Battista Pajno, MD, Daniela Vita, MD, Lucia Caminiti, MD,
What is an “eosinophilic phenotype” of asthma?
Cephalosporin Side Chain Cross-reactivity
H. William Kelly, PharmD  Journal of Allergy and Clinical Immunology 
Personalized asthma therapy in blacks—the role of genetic ancestry
Autophagy: Nobel Prize 2016 and allergy and asthma research
News & Notes Journal of Allergy and Clinical Immunology
The Editors' Choice Journal of Allergy and Clinical Immunology
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Advances in the approach to the patient with food allergy
Evaluation of National Institute of Allergy and Infectious Diseases/Food Allergy and Anaphylaxis Network criteria for the diagnosis of anaphylaxis in.
Prevention of food allergy: Beyond peanut
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Risk of oral food challenges
Benjamin Chaigne, MD, Hervé Watier, MD, PhD 
Eosinophilic esophagitis treated with immunotherapy to dust mites
Reply Journal of Allergy and Clinical Immunology
Thunderstorm-related asthma attacks
Measles and immunomodulation
The Editors' Choice Journal of Allergy and Clinical Immunology
Managing asthma exacerbations in the emergency department: Summary of the National Asthma Education and Prevention Program Expert Panel Report 3 guidelines.
Macrolide antibiotics and asthma treatment
Asthma: The past, future, environment, and costs
Asthma Control Test: Reliability, validity, and responsiveness in patients not previously followed by asthma specialists  Michael Schatz, MD, MS, Christine.
Environmental factors and eosinophilic esophagitis
News & Notes Journal of Allergy and Clinical Immunology
The GILL study: Glycerin-induced local reactions in immunotherapy
Advances in pediatric asthma in 2007
Safety and efficacy of repeated monthly carboplatin desensitization
Natural history of cow’s milk allergy
Primary prevention of asthma and allergy
Presentation transcript:

Imported fire ant field reaction and immunotherapy safety characteristics: The IFACS study  Mark S. La Shell, MD, Christopher W. Calabria, MD, James M. Quinn, MD  Journal of Allergy and Clinical Immunology  Volume 125, Issue 6, Pages 1294-1299 (June 2010) DOI: 10.1016/j.jaci.2010.02.041 Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Number of stings leading to the index field reaction (the SR leading to allergy referral and initiation of IFA SCIT) along with severity of the reaction. Journal of Allergy and Clinical Immunology 2010 125, 1294-1299DOI: (10.1016/j.jaci.2010.02.041) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Total injections by phase. Journal of Allergy and Clinical Immunology 2010 125, 1294-1299DOI: (10.1016/j.jaci.2010.02.041) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 Severity of SRs to IFA SCIT. Seven of 77 patients experienced SRs to IFA SCIT. There were no emergency department visits, hospitalizations, or fatalities. One patient experienced more than 1 SR, and she had a total of 2 SRs, each grade 1. In 2 different patients 2 SRs were delayed (one presented at 35 minutes and the other at 60 minutes). Journal of Allergy and Clinical Immunology 2010 125, 1294-1299DOI: (10.1016/j.jaci.2010.02.041) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions